US 11535663
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
granted A61KA61K38/179A61K38/1866
Quick answer
US patent 11535663 (Methods for producing aflibercept in chemically defined media having reduced aflibercept variants) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/179, A61K38/1866, A61P, A61P17/06